304 filings
Page 6 of 16
6-K
b9jsw5c3bn8bp1nzie6u
19 Apr 18
Current report (foreign)
12:00am
6-K
z12r86y5t n426xvo2
19 Apr 18
Current report (foreign)
12:00am
6-K
vm4521 wgh3dtkel6
6 Apr 18
Current report (foreign)
12:00am
6-K
vmt4ru2
3 Apr 18
Current report (foreign)
12:00am
6-K
4r5qyqynvnd8hyoo05s
14 Mar 18
Current report (foreign)
12:00am
6-K
upx3072oxe csj8t
14 Mar 18
GW Pharmaceuticals Announces Results of Annual General Meeting
12:00am
6-K
rwyaftadpyw vnqhdg
13 Mar 18
Current report (foreign)
12:00am
6-K
uzmqaz3
6 Mar 18
Current report (foreign)
12:00am
6-K
jfxxcp
23 Feb 18
GW Pharmaceuticals Announces Preliminary Results of Phase 2a Study for its Pipeline Compound GWP42006
12:00am
SC 13G/A
g45fdj5kl
14 Feb 18
GW Pharmaceuticals PLC
12:00am
6-K
cymayk
14 Feb 18
Current report (foreign)
12:00am
SC 13G/A
ciolh2sy6irny4
14 Feb 18
Beneficial ownership report (amended)
12:00am
SC 13G/A
rw44prj8m4701scjola
14 Feb 18
GW Pharmaceuticals PLC
12:00am
SC 13G
0qfjew6 4s8nk7x
14 Feb 18
GW Pharmaceuticals PLC
12:00am
SC 13G/A
92ilr1u9f 8i9
14 Feb 18
GW Pharmaceuticals PLC
12:00am
SC 13G/A
j8dvw8bar
13 Feb 18
GW Pharmaceuticals PLC
12:00am
6-K
do3sx77sw7088
5 Feb 18
GW Pharmaceuticals plc Reports Fiscal First Quarter 2018 Financial Results and Operational Progress
12:00am
6-K
6suf6co0l08n
8 Jan 18
Current report (foreign)
12:00am
CT ORDER
as6mrl4qkltb vh5ce8
21 Dec 17
Confidential treatment order
12:00am
6-K
oxqgqignr pu9oa0s
12 Dec 17
GW Pharmaceuticals Announces Proposed Public Offering of ADSs
12:00am